- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means

H.R. 10133
U.S. House•In House Committee
Summary
H.R. 10133, the Fair Prescription Pricing Act of 2026, was introduced in the House on Aug 20, 2026 by Rep. Hillary Scholten (D). It was referred to Energy And Commerce, and last saw action on Aug 20, 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Record
Text
H.R. 10133 has no co-sponsors and has not gone to a roll call.
hb10133/introduced-in-house.txt119 HR 10133 IH: Fair Prescription Pricing Act of 2026U.S. House of Representatives2026-08-20text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.I 119th CONGRESS 2d Session H. R. 10133 IN THE HOUSE OF REPRESENTATIVES August 20, 2026 Ms. Scholten introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committees on Ways and Means , and Education and Workforce , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILLTo amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to ensure cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug.1.Short titleThis Act may be cited as the Fair Prescription Pricing Act of 2026 .2.Ensuring cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug(a)PHSAPart D of title XXVII of the Public Health Service Act ( 42 U.S.C. 300gg–111 et seq. ) is amended by adding at the end the following new section:2799A–12.Limitation on cost sharing for drugs(a)In generalFor plan years beginning on or after the date of the enactment of this section, a group health plan, and a health insurance issuer offering group or individual health insurance coverage, may not impose cost sharing (including deductibles, coinsurance, and copayments) with respect to a covered outpatient drug for which benefits are available under such plan or coverage dispensed by an in-network pharmacy in an amount that exceeds the nationwide average of consumer purchase prices for such drug for the 1-year period ending on the first day of such plan year (as determined using information from the survey described in section 1927(f)(1)(A)(i) of the Social Security Act).(b)Clarification on application to pharmacy benefit managersA group health plan, and a health insurance issuer offering group or individual health insurance coverage, shall ensure that any pharmacy benefit manager providing services under the plan or coverage complies with subsection (a) in the same manner as such subsection applies with respect to such plan or issuer.(c)DefinitionsIn this section:(1)Covered outpatient drugThe term covered outpatient drug has the meaning given such term in section 1927(k) of the Social Security Act.(2)In-network pharmacyThe term in-network pharmacy means, with respect to a group health plan or group or individual health insurance coverage and a drug, a pharmacy with a contractual relationship in effect for dispensing such drug under such plan or coverage..(b)ERISA(1)In generalSubpart B of part 7 of subtitle B of title I of the Employee Retirement Income Security Act of 1974 ( 29 U.S.C. 1185 et seq. ) is amended by adding at the end the following new section:727.Limitation on cost sharing for drugs(a)In generalFor plan years beginning on or after the date of the enactment of this section, a group health plan, and a health insurance issuer offering group coverage, may not impose cost sharing (including deductibles, coinsurance, and copayments) with respect to a covered outpatient drug for which benefits are available under such plan or coverage dispensed by an in-network pharmacy in an amount that exceeds the nationwide average of consumer purchase prices for such drug for the 1-year period ending on the first day of such plan year (as determined using information from the survey described in section 1927(f)(1)(A)(i) of the Social Security Act).(b)Clarification on application to pharmacy benefit managersA group health plan, and a health insurance issuer offering group health insurance coverage, shall ensure that any pharmacy benefit manager providing services under the plan or coverage complies with subsection (a) in the same manner as such subsection applies with respect to such plan or issuer.(c)DefinitionsIn this section:(1)Covered outpatient drugThe term covered outpatient drug has the meaning given such term in section 1927(k) of the Social Security Act.(2)In-network pharmacyThe term in-network pharmacy means, with respect to a group health plan or group health insurance coverage and a drug, a pharmacy with a contractual relationship in effect for dispensing such drug under such plan or coverage..(2)Clerical amendmentThe table of contents in section 1 of such Act is amended by inserting after the item relating to section 715 the following new item:Sec. 727. Limitation on cost sharing for drugs..(c)IRC(1)In generalSubchapter B of chapter 100 of the Internal Revenue Code of 1986 is amended by adding at the end the following new section:9827.Limitation on cost sharing for drugs(a)In generalFor plan years beginning on or after the date of the enactment of this section, a group health plan may not impose cost sharing (including deductibles, coinsurance, and copayments) with respect to a covered outpatient drug for which benefits are available under such plan dispensed by an in-network pharmacy in an amount that exceeds the nationwide average of consumer purchase prices for such drug for the 1-year period ending on the first day of such plan year (as determined using information from the survey described in section 1927(f)(1)(A)(i) of the Social Security Act).(b)Clarification on application to pharmacy benefit managersA group health plan shall ensure that any pharmacy benefit manager providing services under the plan complies with subsection (a) in the same manner as such subsection applies with respect to such plan.(c)DefinitionsIn this section:(1)Covered outpatient drugThe term covered outpatient drug has the meaning given such term in section 1927(k) of the Social Security Act.(2)In-network pharmacyThe term in-network pharmacy means, with respect to a group health plan and a drug, a pharmacy with a contractual relationship in effect for dispensing such drug under such plan..(2)Clerical amendmentThe table of sections for such subchapter is amended by adding at the end the following new item:Sec. 9827. Limitation on cost sharing for drugs..
Tracker
The tracker indicates the progress of this legislation as it moves through the legislative process.
- Introduced2026-08-20
- Passed House
- Passed Senate
- Conference
- To President
- Became Law
To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to ensure cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug.
Sponsors
Rep. Hillary Scholten (D) sponsors H.R. 10133 alone.
Committees
H.R. 10133 went before 3 committees: Education and Workforce, Ways and Means and Energy and Commerce.
Actions
H.R. 10133 has taken 2 actions since Aug 20, 2026.
| Chamber | Action | |||
|---|---|---|---|---|
Aug 20, 2026 | House | Introduced in House | ||
Aug 20, 2026 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.Energy and Commerce Committee |
Votes
H.R. 10133 has not gone to a roll call.
Titles
H.R. 10133 goes by 3 titles, 1 of them short titles.
- Fair Prescription Pricing Act of 2026 — Short Title(s) as Introduced
- Fair Prescription Pricing Act of 2026 — Display Title
- To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to ensure cost sharing for a drug does not exceed the nationwide average of consumer purchase prices for such drug. — Official Title as Introduced
Classification
The Congressional Research Service files H.R. 10133 under Health, one of its 31 policy areas.
CRS Subjects
CRS assigns every bill one policy area from its 31; H.R. 10133’s is Health.
hr10133/policy-areas.txtConstitutional authority
The clause the sponsor cites as Congress’s power to enact H.R. 10133, as entered in the Congressional Record.
[Congressional Record Volume 172, Number 134 (Thursday, August 20, 2026)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. SCHOLTEN:H.R. 10133.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H5249]
Source: congress.gov · legiscan.com